These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 23110887
21. Clinically feasible MTR is sensitive to cortical demyelination in MS. Chen JT, Easley K, Schneider C, Nakamura K, Kidd GJ, Chang A, Staugaitis SM, Fox RJ, Fisher E, Arnold DL, Trapp BD. Neurology; 2013 Jan 15; 80(3):246-52. PubMed ID: 23269598 [Abstract] [Full Text] [Related]
22. Magnetization transfer ratio for assessing remyelination after transcranial ultrasound stimulation in the lysolecithin rat model of multiple sclerosis. Huang LH, Pan ZY, Pan YJ, Yang FY. Cereb Cortex; 2023 Feb 07; 33(4):1403-1411. PubMed ID: 35368059 [Abstract] [Full Text] [Related]
25. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease. Vrenken H, Pouwels PJ, Ropele S, Knol DL, Geurts JJ, Polman CH, Barkhof F, Castelijns JA. Mult Scler; 2007 Jul 07; 13(6):708-16. PubMed ID: 17613597 [Abstract] [Full Text] [Related]
26. Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study. Mesaros S, Rocca M, Sormani M, Valsasina P, Markowitz C, De Stefano N, Montalban X, Barkhof F, Ranjeva J, Sailer M, Kappos L, Comi G, Filippi M. Mult Scler; 2010 Mar 07; 16(3):325-31. PubMed ID: 20086023 [Abstract] [Full Text] [Related]
29. Magnetization transfer ratio measurements of the brain in children with tuberous sclerosis complex. Zikou A, Ioannidou MC, Tzoufi M, Astrakas L, Argyropoulou MI. Pediatr Radiol; 2005 Nov 07; 35(11):1071-4. PubMed ID: 16052334 [Abstract] [Full Text] [Related]
30. Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI. Boretius S, Escher A, Dallenga T, Wrzos C, Tammer R, Brück W, Nessler S, Frahm J, Stadelmann C. Neuroimage; 2012 Feb 01; 59(3):2678-88. PubMed ID: 21914485 [Abstract] [Full Text] [Related]
32. Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis. Laule C, Vavasour IM, Whittall KP, Oger J, Paty DW, Li DK, MacKay AL, Arnold DL. J Neurol; 2003 Aug 01; 250(8):924-31. PubMed ID: 12928910 [Abstract] [Full Text] [Related]
33. Magnetization transfer histogram methodology: its clinical and neuropsychological correlates. van Buchem MA, McGowan JC, Grossman RI. Neurology; 1999 Aug 01; 53(5 Suppl 3):S23-8. PubMed ID: 10496207 [Abstract] [Full Text] [Related]
34. MRI characteristics of familial and sporadic multiple sclerosis patients. Tipirneni A, Weinstock-Guttman B, Ramanathan M, Abdelrahman N, Hussein S, Hagemeier J, Durfee J, Teter BE, Hojnacki D, Dwyer MG, Zivadinov R. Mult Scler; 2013 Aug 01; 19(9):1145-52. PubMed ID: 23232600 [Abstract] [Full Text] [Related]
35. Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis. Zivadinov R, Dwyer MG, Hussein S, Carl E, Kennedy C, Andrews M, Hojnacki D, Heininen-Brown M, Willis L, Cherneva M, Bergsland N, Weinstock-Guttman B. Mult Scler; 2012 Aug 01; 18(8):1125-34. PubMed ID: 22194217 [Abstract] [Full Text] [Related]